Scientist Home Future Health reports clinical trial shows severe eczema symptoms decline with nutritional therapy

• Scientist Home Future Health reported results from a clinical trial of nutritional therapy for severe eczema on Sept. 10, 2026.
• The study showed a meaningful reduction in symptom severity and duration, positioning the program as a potential new treatment option.
• The company highlighted an absorption technology it says supports faster symptom relief, citing improvements within days in some patients.
• SHFH plans a staged investment, starting with intent to acquire 5% equity, with options to raise its stake by 10% then 36%.
• The next phase will focus on immunological analysis, followed by a single-arm, unblinded immunology trial tied to further investment decisions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scientist Home Future Health Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609100742PRIMZONEFULLFEED9824515) on September 10, 2026, and is solely responsible for the information contained therein.